Hybridization biosensor using 2-nitroacridone as electrochemical indicator for detection of short DNA species of Chronic Myelogenous LeukemiaJINGHUA CHEN; JING ZHANG; LIYING HUANG et al.Biosensors & bioelectronics. 2008, Vol 24, Num 3, pp 349-355, issn 0956-5663, 7 p.Article

Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: A case report and review of the literatureBREMER, Celesteann T; LASTRAPES, Ashton; ALPER, Arnold B et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 262-264, issn 0277-3732, 3 p.Article

Bacteremia due to Mycobacterium massiliense in a patient with chronic myelogenous leukemia: case reportHAMAMOTO, Takaaki; YUKI, Atsushi; HOSHINO, Yoshihiko et al.Diagnostic microbiology and infectious disease. 2012, Vol 74, Num 2, pp 183-185, issn 0732-8893, 3 p.Article

Chitosan encapsulated quantum dots platform for leukemia detectionSHARMA, Aditya; CHANDRA MOULI PANDEY; SUMANA, Gajjala et al.Biosensors & bioelectronics. 2012, Vol 38, Num 1, pp 107-113, issn 0956-5663, 7 p.Article

Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemiaMIZUTANI, Shinsuke; KURODA, Junya; SHIMIZU, Daisuke et al.International journal of hematology. 2010, Vol 91, Num 3, pp 516-521, issn 0925-5710, 6 p.Article

The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformationSAHAY, S; PANNUCCI, N. L; MAHON, G. M et al.Oncogene (Basingstoke). 2008, Vol 27, Num 14, pp 2064-2071, issn 0950-9232, 8 p.Article

Role of exosomes released by chronic myelogenous leukemia cells in angiogenesisTAVERNA, Simona; FLUGY, Anna; SAIEVA, Laura et al.International journal of cancer (Print). 2012, Vol 130, Num 9, pp 2033-2043, issn 0020-7136, 11 p.Article

Cytogenetic and Molecular Responses and Outcome in Chronic Myelogenous Leukemia : Need for New Response Definitions?KANTARJIAN, Hagop; O'BRIEN, Susan; JIANQIN SHAN et al.Cancer. 2008, Vol 112, Num 4, pp 837-845, issn 0008-543X, 9 p.Article

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapyPEMMARAJU, Naveen; KANTARJIAN, Hagop; SHAN, Jianqin et al.Haematologica (Roma). 2012, Vol 97, Num 7, pp 1029-1035, issn 0390-6078, 7 p.Article

Genetic mutations in chronic myelogenous leukemia: when to check and what to do?BERMAN, Ellin.Current opinion in hematology. 2012, Vol 19, Num 2, pp 110-116, issn 1065-6251, 7 p.Article

Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia : when to change? A perspective in 2009MAURO, Michael J.Current opinion in hematology. 2009, Vol 16, Num 2, pp 135-139, issn 1065-6251, 5 p.Article

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy?MAHON, François-Xavier; ETIENNE, Gabriel.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 310-322, issn 1078-0432, 13 p.Article

Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression dataYEUNG, K. Y; GOOLEY, T. A; ZHANG, A et al.Bioinformatics (Oxford. Print). 2012, Vol 28, Num 6, pp 823-830, issn 1367-4803, 8 p.Article

TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemiaNAKA, Kazuhito; HOSHII, Takayuki; MURAGUCHI, Teruyuki et al.Nature (London). 2010, Vol 463, Num 7281, pp 676-680, issn 0028-0836, 5 p.Article

Chronic Myeloid Leukemia: A Historical PerspectiveGOLDMAN, John M.Seminars in hematology. 2010, Vol 47, Num 4, pp 302-311, issn 0037-1963, 10 p.Article

Sudden Extramedullary T-Lymphoblastic Blast Crisis in Chronic Myelogenous Leukemia : A Nonrandom Event Associated With Imatinib?KIM, Annette S; GOLDSTEIN, Steven C; LUGER, Selina et al.American journal of clinical pathology. 2008, Vol 129, Num 4, pp 639-648, issn 0002-9173, 10 p.Article

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemiaSWEET, Kendra; AL ALI, Najla H; DALIA, Samir M et al.International journal of hematology. 2014, Vol 100, Num 6, pp 567-574, issn 0925-5710, 8 p.Article

Nilotinib exacerbates diabetes mellitus by decreasing secretion of endogenous insulinITO, Yoshikiyo; MIYAMOTO, Toshihiro; YONG CHONG et al.International journal of hematology. 2013, Vol 97, Num 1, pp 135-138, issn 0925-5710, 4 p.Article

Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR―ABL kinaseSHUXIN LI; ZHENGLIN YAO; YANJIN ZHAO et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 16, pp 5279-5282, issn 0960-894X, 4 p.Article

Chromosome 20q Deletion: A Recurrent Cytogenetic Abnormality in Patients With Chronic Myelogenous Leukemia in RemissionJIANLAN SUN; YIN, C. Cameron; WEI CUI et al.American journal of clinical pathology. 2011, Vol 135, Num 3, pp 391-397, issn 0002-9173, 7 p.Article

Unusual Presentation of Chronic Myelogenous Leukemia as Multiple Skin Chloromas : Report of a Case with Clinical and Cytologic CorrelationSANTHESHIVARA NAGARAJARAO, Harsha; AKHTAR, Israh; HEARD, Ken et al.Acta cytologica. 2009, Vol 53, Num 2, pp 235-238, issn 0001-5547, 4 p.Article

C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cellsBROGNARA, Eleonora; LAMPRONTI, Ilaria; GAMBARI, Roberto et al.European journal of pharmacology. 2011, Vol 672, Num 1-3, pp 30-37, issn 0014-2999, 8 p.Article

Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemiaJIE LI; LIYING XUE; HONGLING HAO et al.Oncology reports. 2012, Vol 27, Num 2, pp 461-466, issn 1021-335X, 6 p.Article

Once-Daily Dasatinib for Treatment of Patients with Chronic Myeloid LeukemiaTYLER, Timothy.The Annals of pharmacotherapy. 2009, Vol 43, Num 5, pp 920-927, issn 1060-0280, 8 p.Article

Bleeding Diathesis in Patients With Chronic Myelogenous Leukemia Receiving Dasatinib TherapyQUINTAS-CARDAMA, Alfonso; KANTARJIAN, Hagop; RAVANDI, Farhad et al.Cancer. 2009, Vol 115, Num 11, pp 2482-2490, issn 0008-543X, 9 p.Article